<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p73 is a p53 homolog that, in vitro, inhibits cell growth and induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>In some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> p73 is monoallelically expressed and this raised the possibility that this gene is subjected to imprinting </plain></SENT>
<SENT sid="2" pm="."><plain>Silencing of p73 in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> and in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> occurs in association with the aberrant methylation of the first exon of the gene </plain></SENT>
<SENT sid="3" pm="."><plain>We have analysed the methylation pattern of the p73 promoter and of upstream and downstream sequences in <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Our results demonstrate that p73 expression in this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is not regulated by methylation </plain></SENT>
<SENT sid="5" pm="."><plain>We concluded that it is unlikely that p73 is imprinted in <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> and that the methylation-dependent silencing of this gene, thus far, is a characteristic of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Oncogene (2000) 19, 4553 - 4556 </plain></SENT>
</text></document>